260 Participants Needed

Virtual Patient Navigation for Breast Cancer

(COUNTS2 Trial)

Recruiting at 1 trial location
LA
Overseen ByLaura Allen
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of California, San Francisco
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

Do I have to stop taking my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications.

What data supports the idea that Virtual Patient Navigation for Breast Cancer is an effective treatment?

The available research shows that Virtual Patient Navigation helps improve breast cancer care by reducing barriers and ensuring timely access to treatment. For example, it has been effective in speeding up the time from positive screening tests to diagnosis and treatment initiation. This is particularly beneficial for disadvantaged women, as it helps them follow up on abnormal mammograms more effectively. While disparities in outcomes still exist, the use of patient navigation programs in hospitals has been shown to improve care for those at risk of delays.12345

What safety data exists for Virtual Patient Navigation in breast cancer treatment?

The provided research does not directly address safety data for Virtual Patient Navigation in breast cancer treatment. The studies focus on the efficacy, feasibility, and broader impacts of patient navigation programs, but do not specifically evaluate safety outcomes or adverse events related to these interventions.16789

Is the Patient Navigation Program a promising treatment for breast cancer?

Yes, the Patient Navigation Program is a promising treatment for breast cancer. It helps patients by reducing barriers to care, improving timely access to treatment, and increasing adherence to screening. It also supports patients in understanding their treatment and can positively impact their family and friends by spreading important health information.167810

What is the purpose of this trial?

This is a feasibility study employing virtual patient navigation for underserved individuals who speak English, Chinese or Spanish and were diagnosed with breast cancer or cardiovascular disease to determine the extent of usability for a virtual patient navigation portal serving people in underserved communities. While not able to entirely replace in-person interactions, virtual patient navigation may be used to expand reach and availability of navigation services to a much greater segment of the population.

Research Team

SL

Scarlett L Gomez, PhD

Principal Investigator

University of California, San Francisco

Eligibility Criteria

This trial is for underserved individuals diagnosed with breast cancer who speak English, Chinese, or Spanish. It aims to test the usability of a virtual patient navigation portal designed to support people in these communities.

Exclusion Criteria

Any medical or psychological conditions precluding informed consent

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Focus Group Development

Initial cohort of focus group participants help develop culturally and language-specific components of the COUNTS program

4 weeks
1-2 visits (virtual or in-person)

Navigation Program

Participants use the online COUNTS portal for navigation support and complete data collection and surveys

6 months
Ongoing virtual interactions

Follow-up

Participants complete a user experience survey at the end of program participation

4 weeks
1 visit (virtual)

Treatment Details

Interventions

  • Patient Navigation Program
Trial Overview The study is testing a virtual patient navigation program combined with survey administration and quality-of-life assessments. The goal is to see if this online approach can effectively extend support services to more patients.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Health services research (Patient COUNTS2)Experimental Treatment3 Interventions
Participants attend focus groups to help further develop the patient portal and navigation program to expand to other groups. Participants use in-person navigation program and complete data collection and surveys over 15 minutes via web portal at baseline and 6 months and user experience survey at end of program participation.

Patient Navigation Program is already approved in United States for the following indications:

🇺🇸
Approved in United States as Patient Navigation Program for:
  • Support for breast cancer patients in underserved communities

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, San Francisco

Lead Sponsor

Trials
2,636
Recruited
19,080,000+

Findings from Research

Patient navigation programs can significantly increase the rates of post-treatment surveillance mammography in women with breast cancer, suggesting a benefit in monitoring after treatment.
However, there is limited evidence that patient navigation improves treatment outcomes during breast cancer care, indicating a need for further research to fully understand its efficacy in this area.
Patient Navigation in Breast Cancer Treatment and Survivorship: A Systematic Review.Baik, SH., Gallo, LC., Wells, KJ.[2019]
Patient navigation (PN) significantly reduced the time from definitive diagnosis to initiation of therapy for breast cancer, with an average of 57 days for the PN group compared to 74 days for the control group, indicating improved efficiency in cancer care.
Hispanic women who received PN were more likely to be diagnosed and start treatment within 60 days of abnormal screening tests, highlighting PN's potential to address health disparities in minority populations.
Beneficial effects of a combined navigator/promotora approach for Hispanic women diagnosed with breast abnormalities.Dudley, DJ., Drake, J., Quinlan, J., et al.[2021]
In a study involving 3,189 patients (1,995 with breast abnormalities and 1,194 with cervical abnormalities), the presence of barriers significantly delayed the time to diagnostic resolution, with adjusted hazard ratios of 0.744 for breast and 0.792 for cervical participants, indicating that barriers negatively impact timely care.
Patient navigators played a crucial role in addressing these barriers by arranging appointments, making referrals, and providing education, suggesting that effective navigation can enhance access to cancer care and improve outcomes.
Barriers reported among patients with breast and cervical abnormalities in the patient navigation research program: impact on timely care.Katz, ML., Young, GS., Reiter, PL., et al.[2021]

References

Patient Navigation in Breast Cancer Treatment and Survivorship: A Systematic Review. [2019]
Beneficial effects of a combined navigator/promotora approach for Hispanic women diagnosed with breast abnormalities. [2021]
Barriers reported among patients with breast and cervical abnormalities in the patient navigation research program: impact on timely care. [2021]
Assessment of patient navigation programs for breast cancer patients across the city of Boston. [2022]
Patient navigation to improve follow-up of abnormal mammograms among disadvantaged women. [2018]
Feasibility of patient navigation in resident primary care practice: a screening mammography quality improvement initiative. [2016]
Navigated African American breast cancer patients as incidental change agents in their family/friend networks. [2023]
Characteristics of the original patient navigation programs to reduce disparities in the diagnosis and treatment of breast cancer. [2011]
Improving patient safety in the inpatient setting through risk assessment and mitigation. [2016]
10.United Statespubmed.ncbi.nlm.nih.gov
The effect of nurse navigation on timeliness of breast cancer care at an academic comprehensive cancer center. [2013]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security